Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Smartphone-Assisted Approach to Formaldehyde Detection Using Diethanolamine-Grafted Carbon Nanoparticles.

ACS omega·2026
Same author

Hierarchically Porous Carbons from Almond Residues via Hydrothermal Pretreatment and Mild K<sub>2</sub>CO<sub>3</sub> Activation for Aqueous Zinc Hybrid Supercapacitors.

Energy & fuels : an American Chemical Society journal·2026
Same author

An Activity-Based Sensing Approach to Monitor Nanomaterial-Promoted Changes in Labile Metal Pools in Living Systems.

Chemical & biomedical imaging·2026
Same author

Macrophage-Mediated <i>In Vivo</i> Intracellular Crystallization of Aluminum Oxyhydroxide Adjuvant in Vaccine-Induced Granulomas.

ACS applied materials & interfaces·2026
Same author

Functional Hybrid Chitosan Coatings With Cu Nanoparticles on the Shape Memory NiTi Enabling Bactericidal Activity.

Journal of biomedical materials research. Part B, Applied biomaterials·2026
Same author

Copper-Collagen Interactions Regulate the Mechanical and Invasive Properties of Tumor Spheroids.

Advanced healthcare materials·2026
Same journal

Correction to "Living Therapeutic Microneedles Integrated with Built-In Metabolic Engines for Autonomous Diabetic Wound Management".

Nano letters·2026
Same journal

Chiral Quasi-Bound States in the Continuum on the Verge of the Light Cone.

Nano letters·2026
Same journal

Scalable Atomically Interfaced Heterostructure Photoelectrodes for Broadband Solar Energy Harvesting and Stable Li-Ion Storage.

Nano letters·2026
Same journal

Bulk and Surface Excitons in the van der Waals Magnet CrSBr: Magneto-Optical Studies to 55 T.

Nano letters·2026
Same journal

High-Entropy Alloy Nanomaterials with Well-Designed Nanostructures for Electrocatalytic Applications.

Nano letters·2026
Same journal

Symmetrical Tetravalent Aptamer-Protein Conjugate with Ultrahigh <i>In Vivo</i> Stability for Targeted Cancer Imaging and Therapy.

Nano letters·2026
See all related articles

Related Experiment Video

Updated: Jun 27, 2026

Preparation of Exosomes for siRNA Delivery to Cancer Cells
09:59

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Published on: December 5, 2018

Extracellular Vesicles as Nanoparticle Delivery Vectors in Cancer Therapy.

Maria Sancho-Albero1,2,3,4, Ana Martín-Pardillos1,3,4,5,6, Jose L Hueso1,2,3,4,7

  • 1Instituto de Nanociencia y Materiales de Aragón (INMA), CSIC-Universidad de Zaragoza, Campus Rio Ebro, Edificio I+D, C/Poeta Mariano Esquillor, s/n, Zaragoza 50018, Spain.

Nano Letters
|June 26, 2026
PubMed
Summary
This summary is machine-generated.

Extracellular vesicles (EVs) show promise for cancer nanomedicine delivery, overcoming low tumor accumulation. Engineering EVs and developing EV-nanoparticle (NP) hybrids are key to improving cancer therapy outcomes.

Keywords:
Extracellular vesicles (EVs)extracellular vesicle engineeringnanoparticle deliverytumor targeting

More Related Videos

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
08:50

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

Manufacture and Drug Delivery Applications of Silk Nanoparticles
09:03

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Published on: October 8, 2016

Related Experiment Videos

Last Updated: Jun 27, 2026

Preparation of Exosomes for siRNA Delivery to Cancer Cells
09:59

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Published on: December 5, 2018

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
08:50

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

Manufacture and Drug Delivery Applications of Silk Nanoparticles
09:03

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Published on: October 8, 2016

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Oncology

Background:

  • Low tumor delivery (<1%) remains a critical challenge for nanoparticle (NP)-based cancer nanomedicine.
  • Biologically derived delivery systems are emerging as a solution to reduce immune clearance and enhance tumor homing.
  • Extracellular vesicles (EVs) offer intrinsic biocompatibility, cell-specific tropism, and biological functionality for drug delivery.

Purpose of the Study:

  • To critically analyze extracellular vesicles (EVs) as nanoparticle delivery vectors for cancer therapy.
  • To review current EV engineering approaches and their associated challenges.
  • To outline research needs for developing EV-nanoparticle (NP) hybrids to overcome delivery barriers in cancer.

Main Methods:

  • Review of current literature on EV engineering for cancer nanomedicine.
  • Analysis of EV loading methodologies and surface modification strategies.
  • Examination of artificial or biomimetic EV development.

Main Results:

  • EVs demonstrate potential for improved cancer therapy due to their inherent properties.
  • Technical, scalability, and characterization challenges exist in current EV engineering approaches.
  • Key in vitro and in vivo results regarding encapsulation, biodistribution, and therapeutic outcomes are summarized.

Conclusions:

  • EVs are promising candidates for overcoming nanoparticle delivery challenges in cancer therapy.
  • Further research is needed to address engineering and characterization hurdles for EV-NP hybrids.
  • Development of EV-NP hybrids is crucial for advancing cancer nanomedicine.